What’s included

CurrentEndo monitors 34 endocrinology, diabetes, obesity, bone and mineral and general medical journals. The list is reviewed each year.

The archive is complete from January 2023 to today.

View journals→

Studies in humans that have an abstract. A Brief is made even when the abstract leaves details out; those are marked as not reported.

Every study in an endocrinology, diabetes, obesity or bone and mineral journal counts as endocrinology research, with the exceptions below for surgery and for fertility treatment and gynecology. In the general medical journals the line is drawn as follows.

General medical journals

Included when the study population is defined by an endocrine condition or a high risk of one, and the study's question concerns that condition, its course or complications, or the care of people with it: diabetes of any type, gestational diabetes and prediabetes; overweight, obesity and lipodystrophy; diseases of the thyroid, the pituitary and hypothalamus, the adrenal glands and the parathyroid glands; disorders of calcium, phosphate and vitamin D metabolism; osteoporosis, fragility fracture and other metabolic bone disease; polycystic ovary syndrome, premature ovarian insufficiency and menopause; hypogonadism; disorders of growth, puberty and sex development; and the hormone treatment of transgender and gender-diverse people. Also included when the primary outcome is the onset, remission or diagnosis of one of these conditions, or the study tests how one is diagnosed. The complications of diabetes are included when the question is their prevention, screening or medical treatment, or their risk in people with diabetes; their local treatment by another specialty, such as eye injections, eye or foot surgery, wound care, amputation or dialysis, is not. A drug class alone does not bring a study in, nor does an endocrine condition as a comorbidity, a subgroup or among secondary or safety outcomes, nor a hormone, glucose, weight or bone measure used only as a marker. Fatty liver disease, lipid disorders, and diet, nutrition and supplements, vitamin D included, are included only in people with diabetes, obesity or another of these conditions, or when one of them is the primary outcome.

Endocrine cancer

Included where the endocrine disease or its management is central: thyroid cancer, radioiodine treatment included, adrenocortical carcinoma, multiple endocrine neoplasia and neuroendocrine tumors, whether or not they secrete hormones. Small-cell and other neuroendocrine carcinomas are not included, nor is general oncology without a substantial endocrine focus, such as cancer of the breast, prostate, ovary or exocrine pancreas and the hormonal treatment of breast or prostate cancer.

Surgery

From any journal, a study whose question is the operation itself is not included: surgical technique, approach or device, one operation compared with another, surgical complications, length of stay, weight loss after bariatric surgery, rehabilitation after surgery and fracture fixation. Whether to operate is a treatment choice: surgery compared with medical or lifestyle treatment, surveillance or not operating is included, and so are the medical care of these conditions around surgery and studies whose own question is remission of diabetes. An endocrine or metabolic outcome after an operation, such as remission, hormone deficiency, hypoparathyroidism or hypoglycemia, is included; where a study measures both such an outcome and the operation's own results, the primary outcome decides.

Fertility and gynecology

From any journal, assisted reproduction such as IVF, fertility treatment that does not treat an endocrine condition, and general gynecology, including endometriosis, fibroids, menstrual disorders and contraception, are not included. Drug treatment of an endocrine condition is included even when the aim is pregnancy, such as ovulation induction in polycystic ovary syndrome. Pregnancy complications other than diabetes and endocrine disease are not included.

Clinical and laboratory research

Studies with human participants, human data or human specimens are included, mechanistic and translational studies in patients and physiological studies in healthy volunteers among them, and so are models built on trial or registry data, such as cost-effectiveness models. Studies only in animals or cells, human cells studied in the laboratory included, only in computer models of the body or only of devices tested on the bench are not; nor are surveys of clinicians' workforce, careers or wellbeing.

Every Brief is placed in one of 14 topics, and the journals are monitored continuously for new research.

Browse topics→